Publisher： Karger
E-ISSN： 1424-8840|28|3|120-126
ISSN： 1424-8832
Source： Pathophysiology of Haemostasis and Thrombosis, Vol.28, Iss.3, 2004-11, pp. : 120-126
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Which Endpoints to Use in Clinical Trials in Venous Thromboembolism?
Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 3, 2004-11 ,pp. :
Are Symptomatic Endpoints Acceptable in Venous Thromboprophylactic Studies?
Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 3, 2004-11 ,pp. :
Treatment of Venous Thromboembolism
Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 3, 2004-11 ,pp. :
The Role of Ximelagatran in the Treatment of Venous Thromboembolism
Pathophysiology of Haemostasis and Thrombosis, Vol. 34, Iss. 1, 2005-04 ,pp. :